Skip to main content

Modalis Therapeutics Corporation

株式会社モダリス

Valuation

Fundamental ratios for the latest reported period.

Ticker: 4883
FY2025 · 2025-12-31
Gross margin
Operating margin
Net margin
Return on equity-78.5%
Return on assets-72.6%
Revenue growth (YoY)
EPS (basic)¥-27.86
EPS growth (YoY)
Current ratio21.46x
Equity ratio92.5%
Book value / share¥31.8
Free cash flow-2,121 M